Tetraphase Pharmaceuticals - 48 Year Dividend History | TTPH

Historical dividend payout and yield for Tetraphase Pharmaceuticals (TTPH) since 1971. The current TTM dividend payout for Tetraphase Pharmaceuticals (TTPH) as of December 05, 2019 is $0.00. The current dividend yield for Tetraphase Pharmaceuticals as of December 05, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.019B
Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio